239 related articles for article (PubMed ID: 34355692)
21. Biochemical analysis of novel NAA10 variants suggests distinct pathogenic mechanisms involving impaired protein N-terminal acetylation.
McTiernan N; Tranebjærg L; Bjørheim AS; Hogue JS; Wilson WG; Schmidt B; Boerrigter MM; Nybo ML; Smeland MF; Tümer Z; Arnesen T
Hum Genet; 2022 Aug; 141(8):1355-1369. PubMed ID: 35039925
[TBL] [Abstract][Full Text] [Related]
22. NAA10 controls osteoblast differentiation and bone formation as a feedback regulator of Runx2.
Yoon H; Kim HL; Chun YS; Shin DH; Lee KH; Shin CS; Lee DY; Kim HH; Lee ZH; Ryoo HM; Lee MN; Oh GT; Park JW
Nat Commun; 2014 Nov; 5():5176. PubMed ID: 25376646
[TBL] [Abstract][Full Text] [Related]
23. NAA10-related syndrome.
Wu Y; Lyon GJ
Exp Mol Med; 2018 Jul; 50(7):1-10. PubMed ID: 30054457
[TBL] [Abstract][Full Text] [Related]
24. The biological functions of Naa10 - From amino-terminal acetylation to human disease.
Dörfel MJ; Lyon GJ
Gene; 2015 Aug; 567(2):103-31. PubMed ID: 25987439
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic and biochemical analysis of an international cohort of individuals with variants in NAA10 and NAA15.
Cheng H; Gottlieb L; Marchi E; Kleyner R; Bhardwaj P; Rope AF; Rosenheck S; Moutton S; Philippe C; Eyaid W; Alkuraya FS; Toribio J; Mena R; Prada CE; Stessman H; Bernier R; Wermuth M; Kauffmann B; Blaumeiser B; Kooy RF; Baralle D; Mancini GMS; Conway SJ; Xia F; Chen Z; Meng L; Mihajlovic L; Marmorstein R; Lyon GJ
Hum Mol Genet; 2019 Sep; 28(17):2900-2919. PubMed ID: 31127942
[TBL] [Abstract][Full Text] [Related]
26. Severe syndromic ID and skewed X-inactivation in a girl with NAA10 dysfunction and a novel heterozygous de novo NAA10 p.(His16Pro) variant - a case report.
Bader I; McTiernan N; Darbakk C; Boltshauser E; Ree R; Ebner S; Mayr JA; Arnesen T
BMC Med Genet; 2020 Jul; 21(1):153. PubMed ID: 32698785
[TBL] [Abstract][Full Text] [Related]
27. Naa10p Inhibits Beige Adipocyte-Mediated Thermogenesis through N-α-acetylation of Pgc1α.
Lee CC; Shih YC; Kang ML; Chang YC; Chuang LM; Devaraj R; Juan LJ
Mol Cell; 2019 Nov; 76(3):500-515.e8. PubMed ID: 31422874
[TBL] [Abstract][Full Text] [Related]
28. Charting the N-Terminal Acetylome: A Comprehensive Map of Human NatA Substrates.
Van Damme P
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639033
[TBL] [Abstract][Full Text] [Related]
29. NAA10 mutation causing a novel intellectual disability syndrome with Long QT due to N-terminal acetyltransferase impairment.
Casey JP; Støve SI; McGorrian C; Galvin J; Blenski M; Dunne A; Ennis S; Brett F; King MD; Arnesen T; Lynch SA
Sci Rep; 2015 Nov; 5():16022. PubMed ID: 26522270
[TBL] [Abstract][Full Text] [Related]
30. Structure and Mechanism of Acetylation by the N-Terminal Dual Enzyme NatA/Naa50 Complex.
Deng S; Magin RS; Wei X; Pan B; Petersson EJ; Marmorstein R
Structure; 2019 Jul; 27(7):1057-1070.e4. PubMed ID: 31155310
[TBL] [Abstract][Full Text] [Related]
31. FIH permits NAA10 to catalyze the oxygen-dependent lysyl-acetylation of HIF-1α.
Kang J; Chun YS; Huh J; Park JW
Redox Biol; 2018 Oct; 19():364-374. PubMed ID: 30237125
[TBL] [Abstract][Full Text] [Related]
32. Human Naa50 Protein Displays Broad Substrate Specificity for Amino-terminal Acetylation: DETAILED STRUCTURAL AND BIOCHEMICAL ANALYSIS USING TETRAPEPTIDE LIBRARY.
Reddi R; Saddanapu V; Chinthapalli DK; Sankoju P; Sripadi P; Addlagatta A
J Biol Chem; 2016 Sep; 291(39):20530-8. PubMed ID: 27484799
[TBL] [Abstract][Full Text] [Related]
33. Implications for the evolution of eukaryotic amino-terminal acetyltransferase (NAT) enzymes from the structure of an archaeal ortholog.
Liszczak G; Marmorstein R
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14652-7. PubMed ID: 23959863
[TBL] [Abstract][Full Text] [Related]
34. The Role of N-α-acetyltransferase 10 Protein in DNA Methylation and Genomic Imprinting.
Lee CC; Peng SH; Shen L; Lee CF; Du TH; Kang ML; Xu GL; Upadhyay AK; Cheng X; Yan YT; Zhang Y; Juan LJ
Mol Cell; 2017 Oct; 68(1):89-103.e7. PubMed ID: 28943313
[TBL] [Abstract][Full Text] [Related]
35. Variants in NAA15 cause pediatric hypertrophic cardiomyopathy.
Ritter A; Berger JH; Deardorff M; Izumi K; Lin KY; Medne L; Ahrens-Nicklas RC
Am J Med Genet A; 2021 Jan; 185(1):228-233. PubMed ID: 33103328
[TBL] [Abstract][Full Text] [Related]
36. ARD1/NAA10 acetylation in prostate cancer.
Kuhns KJ; Zhang G; Wang Z; Liu W
Exp Mol Med; 2018 Jul; 50(7):1-8. PubMed ID: 30054487
[TBL] [Abstract][Full Text] [Related]
37. microRNA-342-5p and miR-608 inhibit colon cancer tumorigenesis by targeting NAA10.
Yang H; Li Q; Niu J; Li B; Jiang D; Wan Z; Yang Q; Jiang F; Wei P; Bai S
Oncotarget; 2016 Jan; 7(3):2709-20. PubMed ID: 26646451
[TBL] [Abstract][Full Text] [Related]
38. From Molecular Understanding to Organismal Biology of N-Terminal Acetyltransferases.
Lyon GJ
Structure; 2019 Jul; 27(7):1053-1055. PubMed ID: 31269458
[TBL] [Abstract][Full Text] [Related]
39. Molecular basis for N-terminal acetylation by human NatE and its modulation by HYPK.
Deng S; McTiernan N; Wei X; Arnesen T; Marmorstein R
Nat Commun; 2020 Feb; 11(1):818. PubMed ID: 32042062
[TBL] [Abstract][Full Text] [Related]
40. N-α-acetyltransferase 10 protein promotes metastasis by stabilizing matrix metalloproteinase-2 protein in human osteosarcomas.
Chien MH; Lee WJ; Yang YC; Tan P; Pan KF; Liu YC; Tsai HC; Hsu CH; Wen YC; Hsiao M; Hua KT
Cancer Lett; 2018 Oct; 433():86-98. PubMed ID: 29960050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
